Quick Answer
Probiotics Sleep Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: It is estimated that fibromyalgia can result in up to approximately 36 000$ of annual direct costs per patient in the US, imposing a considerable burden on the health care systems.
Key Takeaways
- 01It is estimated that fibromyalgia can result in up to approximately 36 000$ of annual direct costs per patient in the US, imposing a considerable burden on the health care systems. [Nakhostin-Ansari Amin (2026)]
- 02The presence of these comorbid medical conditions can make the diagnosis of fibromyalgia challenging, which could lead to mismanagement, overtreatment, and increased drug side effects. [Nakhostin-Ansari Amin (2026)]
- 03Therefore, proper diagnosis of fibromyalgia and its associated comorbidities is crucial for effective management of the conditions. [Nakhostin-Ansari Amin (2026)]
- 041 2 [,] 3 [] 4 [] 5 6 [,] 7 8 [,] 7 8 [,] 5 [] Fibromyalgia is a syndrome characterized by chronic widespread musculoskeletal pain, often accompanied by a range of other symptoms, including sleep disturbances, excessive fatigue, and psychological issues such as depression. [Nakhostin-Ansari Amin (2026)]
The current Migaku evidence database contains 2 reusable source documents for Probiotics Sleep Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- It is estimated that fibromyalgia can result in up to approximately 36 000$ of annual direct costs per patient in the US, imposing a considerable burden on the health care systems. [Nakhostin-Ansari Amin (2026); evidence level 1]
- The presence of these comorbid medical conditions can make the diagnosis of fibromyalgia challenging, which could lead to mismanagement, overtreatment, and increased drug side effects. [Nakhostin-Ansari Amin (2026); evidence level 1]
- Therefore, proper diagnosis of fibromyalgia and its associated comorbidities is crucial for effective management of the conditions. [Nakhostin-Ansari Amin (2026); evidence level 1]
- 1 2 [,] 3 [] 4 [] 5 6 [,] 7 8 [,] 7 8 [,] 5 [] Fibromyalgia is a syndrome characterized by chronic widespread musculoskeletal pain, often accompanied by a range of other symptoms, including sleep disturbances, excessive fatigue, and psychological issues such as depression. [Nakhostin-Ansari Amin (2026); evidence level 1]
- 6 7 8 9 Insufficient sleep and poor sleep quality are associated with daytime sleepiness and reduced performance and are also linked to increased metabolic and cardiovascular risk and adverse mental health outcomes []. [Kim Hayoung (2026); evidence level 2]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources